CDER New October 26, 2015

What's New on the FDA Drugs Site

October 23, 2015

• Drug Firm Annual Registration Status (updated)
• Drug Firm Annual Registration Status Download File (updated)
• Public Notifications
  • Public Notification: Wild Sexx Capsules contain hidden drug ingredients
  • Public Notification: Ultra SX Capsules contain hidden drug ingredient
  • Public Notification: Super Dragon 6000 Capsules contain hidden drug ingredient
  • Public Notification: Sex-Love Secret Code Capsules contain hidden drug ingredient
  • Public Notification: Paradise Suplemento Natural Ultra Plus Capsules contain hidden drug ingredient
  • Public Notification: APEXXX Contains Hidden Drug Ingredient
  • Public Notification: Fuel Up High Octane contains hidden drug ingredient
  • Public Notification: Fuel Up Plus contains hidden drug ingredient
  • Public Notification: S.W.A.G.G.E.R Extreme Capsules contain hidden drug ingredient
  • Public Notification: Xtreme Fat Burner Capsules contain hidden drug ingredients
  • Public Notification: Tip-Top Shape contains hidden drug ingredient
  • Public Notification: Lishou Slimming Coffee contains hidden drug ingredient
  • Public Notification: Basha Nut 100% Fruit Soft Gel Capsules contain hidden drug ingredient
• FDA Drug Shortages
  • Calcium Gluconate Injection   (Updated - Currently in Shortage)
  • Cefazolin Injection   (Updated - Currently in Shortage)
  • Cefepime Injection   (Updated - Currently in Shortage)
  • Chloramphenicol Sodium Succinate Injection   (Updated - Currently in Shortage)
  • Doxorubicin (Adriamycin) Injection   (Updated - Currently in Shortage)
  • Lidocaine Hydrochloride (Xylocaine) Injection   (Updated - Currently in Shortage)
  • Nebivolol (BYSTOLIC) Tablets   (Currently in Shortage)
  • Piperacillin and Tazobactam (Zosyn) Injection   (Updated - Currently in Shortage)
  • Potassium Chloride Injection (Updated - Currently in Shortage)
  • Sodium Chloride 23.4% Injection (Updated - Currently in Shortage)
  • Vancomycin Hydrochloride for Injection, USP (Updated - Currently in Shortage)
• Manual of Policies and Procedures (MAPP) 5017.1 Office of Biotechnology Products and Office of Compliance, Office of Manufacturing Quality Interactions on BLA Assessments (PDF - 111KB)
• National Drug Code Directory
• Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)